New method to isolate tiny particles for delivering RNA
Novel, Scalable Approach for Isolation of Exomeres for RNA Delivery
['FUNDING_R21'] · MICHIGAN STATE UNIVERSITY · NIH-11062542
This study is exploring tiny particles called exomeres that help cells talk to each other by carrying important messages, with the goal of finding better ways to use them in treatments that deliver helpful genetic material to patients.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MICHIGAN STATE UNIVERSITY (nih funded) |
| Locations | 1 site (EAST LANSING, UNITED STATES) |
| Trial ID | NIH-11062542 on ClinicalTrials.gov |
What this research studies
This research investigates a novel class of nanoparticles called exomeres, which play a crucial role in cell communication by delivering microRNAs (miRNAs) between cells. The project aims to develop a scalable approach for isolating these exomeres, which are smaller and have unique properties compared to traditional extracellular vesicles. By understanding how exomeres are formed and how they can be used to deliver therapeutic RNA molecules, the research seeks to enhance the effectiveness of RNA-based treatments. Patients may benefit from improved therapies that utilize these nanoparticles for targeted delivery of genetic material.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from RNA therapies, such as cancer or genetic disorders.
Not a fit: Patients who do not have conditions treatable with RNA-based therapies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective RNA-based therapies for various diseases.
How similar studies have performed: While the concept of using nanoparticles for RNA delivery is established, the specific focus on exomeres represents a novel approach that has not been extensively tested.
Where this research is happening
EAST LANSING, UNITED STATES
- MICHIGAN STATE UNIVERSITY — EAST LANSING, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WALTON, STEPHEN PATRICK — MICHIGAN STATE UNIVERSITY
- Study coordinator: WALTON, STEPHEN PATRICK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.